- Published at
- by insidermonkey.com
neutral
neutral
Lantern Pharma Inc. (LTRN) Enhances RADR® AI Platform to Accelerate Development of Antibody-Drug Conjugates (ADCs) for Targeted Cancer Therapies
The artificial intelligence community is raving over a new reasoning model that has surprised even Silicon Valley.